About NOVELMED THERAPEUTICS, INC.
NovelMed is a clinical-stage biotechnology company based in Ohio, specializing in the development of novel biologics targeting the Complement Alternative Pathway for both rare and non-rare diseases. The company is focused on creating innovative antibody therapies with a strong intellectual property foundation and promising clinical trial results.
Development of novel biologics targeting the Complement Alternative PathwayCreation of neutralizing monoclonal antibodies for chronic diseasesR&D strategies focused on selective pathway blocking for enhanced safetyClinical trials for multiple complement-mediated diseases including PNH, IgAN, C3G, aHUS, and others
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NOVELMED THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.